The Royal Pharmaceutical Society (RPS) has called for changes to allow for the unrestricted, legitimate research of controlled drugs in response to a consultation from the Advisory Council on the Misuse of Drugs (ACMD).
Clinicians in the UK should have the option to prescribe cannabis-derived medicinal products where appropriate, drug experts have concluded, paving the way for laws prohibiting their use to be relaxed.